High Myopia: Extended and Longterm Observation of Pathologic Myopia Patients With the Risk for Developing a Myopic Choroidal Neovascularization (CNV)
Clinical trial NCT03070717 · COMPLETED
Trial details
- NCT number
- NCT03070717
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-06-12
- Primary completion
- 2019-05-23
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.